LakeShore Biopharma Co., Ltd: rnd_expense
| Value | {"unit": "CNY", "value": 318700526, "concept": "us-gaap:ResearchAndDevelopmentExpense"} |
|---|---|
| Period | 2022-04-01 – 2023-03-31 |
| Status | superseded |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5422c894-0731-4c3b-9774-4cc7dba465b6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-060012Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/rnd-expense/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5422c894-0731-4c3b-9774-4cc7dba465b6
History
- no predecessors — first report